PRNews

Botanee & Winona Shines at COSMETIC 360: VOGUE FRANCE, Le Figaro Highlight its Award-Winning Innovations

Cision | Thu, Oct 24 2024 08:41 PM AEDT

1695367561_650d4189d32c8_1692951951_64e8658fe70f4_breaking_news_600.png
Image Source: Sivastatz

PARIS, Oct. 24, 2024 /PRNewswire/ -- Winona, a leading cosmeceutical brand in China owned by the Botanee Group, is making its mark on the international stage with groundbreaking plant-based innovations in beauty. Its innovative approach has just earned recognition at COSMETIC 360, the world's leading trade fair for innovations and trends in the perfume and cosmetics industry.

In the 10th COSMETIC 360, held at the prestigious Carrousel du Louvre, Botanee won the 2024 INPD AWARDS-Raw Materials and the COSMETOPIADS-Public Research Excellence award, highlighting its unmatched excellence in raw material innovation and leadership in groundbreaking cosmetic research. Vogue France and Le Figaro have cast a spotlight on Botanee's outstanding achievements, further enhancing the brand's influence in the industry.

From top to bottom: Botanee&Winona product; Coverage by VOGUE FRANCE, Le Figaro
From top to bottom: Botanee&Winona product; Coverage by VOGUE FRANCE, Le Figaro

Winona: Pioneering Plant-Based Innovation from Yunnan, China

Central to Winona's success is Botanee's cutting-edge research on medicinal plants native to Yunnan Province. It has extensively explored over 6,500 species and ranks No. 1 in China for new plant-based materials filed with the National Medical Products Administration (NMPA), China's regulatory authority for cosmetics, with a total of 11 approvals.

A prime example of this innovation is Winona's second-generation Sensitive Cream, which incorporates the rare Prinsepia utilis Royle extract—a patented breakthrough that has already received acclaim in China, including the "New Product of the Year" award at the 2024 Tmall Golden Makeup Awards. Winona's dedication to harnessing nature's best for skincare exemplifies its commitment to quality and efficacy.

From China to France, from France to the world

Botanee has a targeted global expansion strategy, centered on nurturing collaboration between industry, academic, research and pharmaceutical sectors.

With the Botanee Research Institute centered in Shanghai, the group expanded laboratories and international research centers in Kunming, Paris, and Japan during 2022 and 2023, laying the foundation for Botanee's global R&D footprint.

From people to planet, bringing sustainable health and beauty to all

As an ESG-focused company, Botanee is dedicated to long-term biodiversity protection. To date, the Botanee Charity Fund has invested over 50 million RMB in ESG projects.

As Botanee continue its global expansion, it remains resolute in its mission to bring health and beauty to all. With a steadfast commitment to innovation, sustainability, and global collaboration, Winona is poised to redefine the evolving landscape of global beauty.

About Winona

Founded in 2008, Winona is China's first cosmeceutical skincare brand, specializing in sensitive skin. The brand was developed independently and validated through clinical trials. According to Euromonitor, its parent company, Botanee Group, is currently the top cosmeceutical brand in China by market share, boasting an impressive and diverse portfolio that includes beloved brands such as Winona Baby, AOXMED, Beforteen, Pure&Mild, and ZA.

In 2023, Botanee Group achieved a remarkable annual revenue of 5.52 billion RMB, with a significant 335 million RMB dedicated to R&D, positioning it among the top leaders in R&D investment within China's industry.

 

PRNews

Corporates Continue to Embed Sustainability in Core Business Strategies

SHANGHAI, Oct. 24, 2024 /PRNewswire/ -- Amidst the evolving global energy landscape and a growing climate crisis, ESG-focused brands are playing a ...

Cision | Thu, Oct 24 2024 11:01 PM AEDT

Read More
PRNews

Medera Announces Completion of Cohort A and Initiation of Dosing in Cohort B of MUSIC-HFpEF, a Phase 1/2a Clinical Trial Evaluating First-In-Human Gene Therapy SRD-002 for Heart Failure with Preserved Ejection Fraction

Heart failure is a global pandemic with an estimated 64.3 million cases worldwide, costing over US$100B per year Heart failure ...

Cision | Thu, Oct 24 2024 11:00 PM AEDT

Read More
PRNews

Hithium Announces MSA with EVLO and First Commissioned Project with its High-Density 5 MWh DC block in North America

MONTREAL, Oct. 24, 2024 /PRNewswire/ -- Hithium, a leading global provider of integrated energy storage products and solutions announces the signing of ...

Cision | Thu, Oct 24 2024 11:00 PM AEDT

Read More
PRNews

NaaS Technology Rapidly Expands Charger Connections, Enhances Supply-Side Infrastructure

BEIJING, Oct. 24, 2024 /PRNewswire/ -- NaaS Technology Inc. (Nasdaq: NAAS) ("NaaS" or the "Company"), the first U....

Cision | Thu, Oct 24 2024 11:00 PM AEDT

Read More
PRNews

SunCar Technology Expands Strategic Partnership with Ping An Property & Casualty Across Key Provinces

New and Renewed Contracts Totaling 30 million RMB to Enhance Automotive Services Nationwide NEW YORK, Oct. 24, 2024 /PRNewswire/ -- SunCar Technology Group ...

Cision | Thu, Oct 24 2024 11:00 PM AEDT

Read More